📰 Vcel News
Vcel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vcel. Real-time updates on events, politics, business and more.
May 6, 2024
Vericel (NASDAQ:VCEL – Get Free Report) and Genocea Biosciences (NASDAQ:GNCAQ – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings. Analyst Recommendations This is a breakdown of recent ratings […]
April 27, 2024
Louisiana State Employees Retirement System bought a new position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 23,900 shares of the biotechnology company’s stock, valued at approximately $851,000. Louisiana State Employees Retirement System owned 0.05% of Vericel […]
March 29, 2024
Truist Financial reissued their buy rating on shares of Vericel (NASDAQ:VCEL – Free Report) in a research note released on Tuesday, Benzinga reports. The firm currently has a $54.00 price target on the biotechnology company’s stock. Other equities analysts also recently issued research reports about the company. HC Wainwright upped their price objective on Vericel […]
February 29, 2024
Vericel Co. (NASDAQ:VCEL – Get Free Report) shares fell 7.4% during mid-day trading on Thursday . The stock traded as low as $43.87 and last traded at $44.27. 384,117 shares traded hands during trading, a decline of 40% from the average session volume of 635,116 shares. The stock had previously closed at $47.80. Wall Street […]
February 25, 2024
Shares of Vericel Co. (NASDAQ:VCEL – Get Free Report) have been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in […]
February 20, 2024
Vericel Co. (NASDAQ:VCEL – Get Free Report) shares hit a new 52-week high on Tuesday . The company traded as high as $50.09 and last traded at $49.84, with a volume of 282501 shares changing hands. The stock had previously closed at $49.20. Wall Street Analyst Weigh In A number of brokerages recently commented on […]
February 20, 2024
Shares of Vericel Co. (NASDAQ:VCEL – Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as $50.09 and last traded at $49.84, with a volume of 282501 shares. The stock had previously closed at $49.20. Wall Street Analysts Forecast Growth Several research analysts have commented on […]
February 2, 2024
Vericel Co. (NASDAQ:VCEL – Get Free Report) Director Robert L. Md Zerbe sold 2,300 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $44.22, for a total transaction of $101,706.00. Following the transaction, the director now directly owns 23,395 shares in […]
January 31, 2024
Shares of Vericel Co. (NASDAQ:VCEL – Get Free Report) have been given an average rating of “Buy” by the six analysts that are presently covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have issued ratings on the stock […]
January 28, 2024
Vericel Co. (NASDAQ:VCEL – Get Free Report) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 2,410,000 shares, a drop of 58.8% from the December 31st total of 5,850,000 shares. Based on an average daily volume of 482,300 shares, the days-to-cover ratio is […]